Home > Resources > Whitepapers > Three Challenges Facing Study Start Up and the Low-Code Solution

Research, PHARMACY MARKET

Three Challenges Facing Study Start Up and the Low-Code Solution

December 22, 2022

Three Challenges
The life sciences industry has been exploring ways to
accelerate the study start up process for well over a decade.
The industry has long understood the value behind faster
clinical trials: the sooner clinical trial results can be delivered
to agencies, the sooner a new treatment can be available for
patients.

I'm For Real

Enter your details once to access all our information and resources

Spotlight

Pharma Tech Industries

Pharma Tech Industries is a family owned and operated pharmaceutical contract manufacturing organization offering fully-integrated supply chain support and highly customized production services to many of the most trusted pharmaceutical and wellness companies in the world. We filled our first products in 1972 in the small town of Union, Missouri and, over the next 40 years, grew to be the largest pharmaceutical contract manufacturer and packager of powder products.

OTHER WHITEPAPERS
news image

Shining a Light on Lipid Nanoparticle Characterization

whitePaper | October 3, 2022

Next-Generation Synthetic Biology Workflow Platform Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences.

Read More
news image

Manual No More: Automating the Scientific Data Lifecycle

whitePaper | May 23, 2022

The world’s scientific data today is a morass. 50-80% of research scientist and data scientist time is spent wrestling with data before they can focus on highervalue AI/ML and advanced analysis to help bring new life-saving therapeutics to market.

Read More
news image

Pharma R&D Annual Review

whitePaper | March 15, 2022

Successes in 2021 – New active substance drug launches

Read More
news image

Market Access Trends in the US, Europe, and Emerging Markets

whitePaper | November 14, 2022

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Read More
news image

Achieving diversity, equity and inclusion in clinical trials

whitePaper | April 26, 2022

The prevalence of communicable and non-communicable diseases are increasing worldwide, placing considerable demand on public health systems and driving a necessity to develop more effective targeted therapies.

Read More
news image

Securing the modern pharmaceutical supply chain

whitePaper | April 22, 2022

Members of the Health-ISAC community have produced a security framework for the pharmaceutical supply chain comprising this CISO guide.

Read More

Shining a Light on Lipid Nanoparticle Characterization

whitePaper | October 3, 2022

Next-Generation Synthetic Biology Workflow Platform Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences.

Read More

Manual No More: Automating the Scientific Data Lifecycle

whitePaper | May 23, 2022

The world’s scientific data today is a morass. 50-80% of research scientist and data scientist time is spent wrestling with data before they can focus on highervalue AI/ML and advanced analysis to help bring new life-saving therapeutics to market.

Read More

Pharma R&D Annual Review

whitePaper | March 15, 2022

Successes in 2021 – New active substance drug launches

Read More

Market Access Trends in the US, Europe, and Emerging Markets

whitePaper | November 14, 2022

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Read More

Achieving diversity, equity and inclusion in clinical trials

whitePaper | April 26, 2022

The prevalence of communicable and non-communicable diseases are increasing worldwide, placing considerable demand on public health systems and driving a necessity to develop more effective targeted therapies.

Read More

Securing the modern pharmaceutical supply chain

whitePaper | April 22, 2022

Members of the Health-ISAC community have produced a security framework for the pharmaceutical supply chain comprising this CISO guide. 

Read More
More Whitepapers

Spotlight

Pharma Tech Industries

Pharma Tech Industries is a family owned and operated pharmaceutical contract manufacturing organization offering fully-integrated supply chain support and highly customized production services to many of the most trusted pharmaceutical and wellness companies in the world. We filled our first products in 1972 in the small town of Union, Missouri and, over the next 40 years, grew to be the largest pharmaceutical contract manufacturer and packager of powder products.

Events

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

Conference